JAK1 and neoplasm: Tumor cells are associated with molecular alterations, including, but not limited to, mutations of Kirsten rat sarcoma viral oncogene (Kras), focal adhesion kinase (FAK), and Janus kinase 1/2 (JAK1/2), which directly influence the TIME and immune function.